MapLight Therapeutics (MPLT) Return on Assets (2025)
MapLight Therapeutics (MPLT) reported Return on Assets of 0.0% for Q4 2025.
MapLight Therapeutics (MPLT) Return on Assets (2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 1 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Assets changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed N/A YoY), and the FY2025 full-year result was 0.01%, changed N/A from the prior year.
- Return on Assets steadied at 0.0% in Q4 2025.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -0.80% |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 0.00% |
| 10 | MapLight Therapeutics | 314.07 Mn | 314.07 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |